Edwards Lifesciences logo

Edwards LifesciencesNYSE: EW

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 March 2000

Next earnings report:

06 February 2025

Last dividends:

N/A

Next dividends:

N/A
$40.97 B
-49%vs. 3y high
98%vs. sector
-81%vs. 3y high
11%vs. sector
-70%vs. 3y high
77%vs. sector
-61%vs. 3y high
67%vs. sector

Price

pre-market | 37 min ago
$69.46-$0.92(-1.31%)

Dividend

No data over the past 3 years
$1.35 B$1.37 B
$1.35 B$3.07 B

Analysts recommendations

Institutional Ownership

EW Latest News

Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
prnewswire.com21 November 2024 Sentiment: NEGATIVE

NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm has an announcement for shareholders of Edwards Lifesciences Corporation (NYSE: EW). Those who bought shares of EW during the specified time are invited to reach out to the firm about the chance to be appointed as lead plaintiff.

Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW
accesswire.com20 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112912&wire=1 or reach out to Joseph E. Levi, Esq.

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
accesswire.com20 November 2024 Sentiment: NEGATIVE

James (Josh) Wilson, a partner at Faruqi & Faruqi, LLP, is urging investors who lost over $100,000 in Edwards between February 6, 2024, and July 24, 2024, to reach out to him to explore their legal options. Interested individuals can contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Additionally, Faruqi & Faruqi is looking into possible claims against Edwards Lifesciences Corporation and reminds investors that the deadline to apply as lead plaintiff in a federal securities class action is December 13, 2024.

Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
accesswire.com20 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112895&wire=1 or reach out to Joseph E. Levi, Esq.

Did EDWARDS LIFESCIENCES (EW) Commit Securities Fraud? If You Suffered Losses on Your Investment Contact BFA Law about the Ongoing Class Action Lawsuit
accesswire.com20 November 2024 Sentiment: NEGATIVE

On November 20, 2024, Bleichmar Fonti & Auld LLP, a prominent securities law firm, announced that a lawsuit has been initiated against Edwards Lifesciences Corporation (NYSE:EW) and some of its top executives for possible breaches of federal securities laws. If you have invested in Edwards Lifesciences, you are invited to find more details by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.

Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
accesswire.com20 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112875&wire=1 or reach out to Joseph E. Levi, Esq.

Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation
accesswire.com20 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 20, 2024 / The Schall Law Firm, a national firm focused on shareholder rights, is reminding investors about a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW). This lawsuit claims violations of the Securities Exchange Act of 1934 and related rules by the U.S. Securities and Exchange Commission. Investors who bought the Company's securities between February 6, 2024, and July 24, 2024, are urged to reach out to the firm before December 13, 2024.

Levi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW
accesswire.com20 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=112870&wire=1 or reach out to Joseph E. Levi, Esq.

EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
prnewswire.com20 November 2024 Sentiment: NEGATIVE

SAN DIEGO, Nov. 20, 2024 /PRNewswire/ -- The law firm Robbins Geller Rudman & Dowd LLP has announced that individuals who bought or acquired securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024, and July 24, 2024, have until Friday, December 13, 2024, to apply for the role of lead plaintiff in the class action lawsuit against Edwards Lifesciences. The case is titled Patel v.

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
accesswire.com20 November 2024 Sentiment: NEGATIVE

Investors in Edwards Lifesciences Corporation (NYSE:EW) who have experienced significant losses are encouraged to report their losses. The class action lawsuit covers the period from February 6, 2024, to July 24, 2024, with a deadline for lead plaintiffs set for December 13, 2024. The case examines whether the company properly disclosed information regarding its main product, the Transcatheter Aortic Valve Replacement (TAVR) platform.

What type of business is Edwards Lifesciences?

Edwards Lifesciences Corporation is an American company headquartered in Irvine, California, specializing in the production and distribution of medical equipment for monitoring structural heart diseases and intensive therapy. It was founded in 1958. It is the world's leading manufacturer of cardiovascular system valves and means for their replacement or repair. It is also a global leader in the field of hemodynamic monitoring systems used to measure the cardiovascular function of patients. The company's products and solutions can be divided into several groups: transcatheter therapy, surgical therapy, intensive therapy.

What sector is Edwards Lifesciences in?

Edwards Lifesciences is in the Healthcare sector

What industry is Edwards Lifesciences in?

Edwards Lifesciences is in the Medical Devices industry

What country is Edwards Lifesciences from?

Edwards Lifesciences is headquartered in United States

When did Edwards Lifesciences go public?

Edwards Lifesciences initial public offering (IPO) was on 27 March 2000

What is Edwards Lifesciences website?

https://www.edwards.com

Is Edwards Lifesciences in the S&P 500?

Yes, Edwards Lifesciences is included in the S&P 500 index

Is Edwards Lifesciences in the NASDAQ 100?

No, Edwards Lifesciences is not included in the NASDAQ 100 index

Is Edwards Lifesciences in the Dow Jones?

No, Edwards Lifesciences is not included in the Dow Jones index

When was Edwards Lifesciences the previous earnings report?

No data

When does Edwards Lifesciences earnings report?

The next expected earnings date for Edwards Lifesciences is 06 February 2025